Cervical cancer, long a leading cause of premature death among women worldwide, may soon be the first cancer eliminated as a public health problem, following sharply accelerated progress on several continents, according to recent data and a milestone global commentary released by the World Health Organization (WHO) on November 17, 2026.

The WHO’s 2020 Global Strategy to Accelerate the Elimination of Cervical Cancer set ambitious targets: reaching 90% HPV vaccination for girls, 70% screening among women, and 90% access to treatment for those diagnosed. In just six years, momentum has shifted dramatically. Australia and Sweden now stand on the verge of achieving the WHO’s public health elimination benchmarks, driven by robust HPV vaccination strategies and widespread screening programs. Australia, a global leader, has demonstrated near-universal HPV vaccination rates and deep integration of screening into routine care, leading to a precipitous drop in new cases. Sweden has mirrored this trajectory with its aggressive screening and vaccination policies.

This breakthrough is not limited to affluent countries. Rwanda has emerged as a model for the African continent, integrating HPV vaccine into its national immunization program and expanding screening and treatment nationwide. Several of its districts have already reached the WHO’s elimination targets, offering proof that even resource-constrained countries can achieve these historic milestones when political commitment aligns with community engagement.

As of November 2026, the campaign has propelled 166 countries—including newcomers Burundi, Papua New Guinea, and Ukraine—to introduce HPV vaccination into national immunization programs. India’s recent drive alone reached over 11 million girls. New scientific evidence now supports simplified, single-dose regimens for most girls; ninety-six countries have moved to this easier, more affordable format, increasing reach and compliance.

Advances in detection and treatment are further accelerating progress. More countries have adopted HPV testing, which is both more effective and less invasive than traditional Pap smears, and can allow women to self-sample in privacy. Portable ablation devices now permit nurses to treat precancerous lesions in minutes, even in the most remote settings.

The human face of this campaign has also galvanized public support. Survivors and local advocates across Kenya, Sierra Leone, Zambia, and Malaysia organize vaccination drives, lead screening campaigns, and provide support for recovering patients. In Zambia, a survivor network now numbers more than 100,000 women.

Despite these promising advances, formidable challenges remain. Vaccination, screening, and treatment rates lag significantly in the world’s poorest communities. Nineteen of the twenty nations with the highest cervical cancer burdens are in Africa, where women continue to face not only disease and financial hardship but also stigma and reduced access to care. Addressing these persistent inequalities remains essential to turning the vision of elimination into a universal reality.

With November 17 now marked as World Cervical Cancer Elimination Day by the World Health Assembly, the unprecedented effort harnesses scientific progress, political will, and the stories and strength of women globally. If current momentum continues, this could mark the first time in history that a cancer is eliminated as a threat to public health, carrying lessons for future disease eradication campaigns worldwide.